The Vanguard Study: Testing a New Way to Screen for Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Bayer
Neonc Technologies, Inc.
ViroMissile, Inc.
Arcus Biosciences, Inc.
Jazz Pharmaceuticals
Qurient Co., Ltd.
Duke University
Essen Biotech
Genentech, Inc.
Eli Lilly and Company
SystImmune Inc.
Daiichi Sankyo
Eli Lilly and Company
Perspective Therapeutics
Second Life Therapeutics
Novartis
Tanabe Pharma America, Inc.
University Health Network, Toronto
NeoTX Therapeutics Ltd.
Laekna Limited
University of Pittsburgh
Tempus AI
Incyte Corporation
Actym Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Pfizer
Arcus Biosciences, Inc.
Washington University School of Medicine
Merck Sharp & Dohme LLC
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Cancer Research UK
Novita Pharmaceuticals, Inc.
NuCana plc
University of Virginia
Telix Pharmaceuticals (Innovations) Pty Limited
Marengo Therapeutics, Inc.
Anhui Provincial Hospital
ModeX Therapeutics, An OPKO Health Company
Ascentage Pharma Group Inc.
Cancer Research UK
NGM Biopharmaceuticals, Inc
University Hospital, Antwerp
Revolution Medicines, Inc.
Elevation Oncology
Stanford University
Seagen Inc.
Immatics US, Inc.